The Pharmaceutical Excipients market will register a 7.8% CAGR in terms of revenue, the global market size will reach $ US$ 1432.9million by 2027.
Phenylketonuria (PKU) is caused due a defect in the gene which helps to produce phenylalanine hydroxylase. Absence of phenylalanine hydroxylase leads to a buildup of phenylalanine in the body. Timely diagnosis and treatment help in terminating the symptoms of PKU and avoid brain damage. Phenylketonuria is an inherited genetic condition caused due to a defect in the PAH gene. The PAH gene is responsible for the production of phenylalanine hydroxylase for breakdown of phenylalanine. Increased levels of phenylalanine can occur due to high intake of protein, such as eggs and meat. For an infant to inherit phenylketonuria, both parents must pass on a defective version of the PAH gene.
Based on the Phenylketonuria (PKU) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
Top Key players in the Phenylketonuria (PKU) Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Phenylketonuria (PKU) Market is fragmented with a large number of small players operating worldwide. The companies referred in the market research report includes Biomarin, Vitaflo, Mead Johnson, Nutricia, Abbott, Dr. Schär, Prominmetabolics, Cambrooke, Juvela, Firstplay Dietary and others.
2020 BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a pioneer in developing treatments for phenylketonuria (PKU) and gene therapies, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BMN 307, investigational gene therapy for the treatment of individuals with PKU.
Market is segmented based on the type, applications, companies and regions.
By Type, Phenylketonuria (PKU) Market has been segmented into
By Type, Phenylketonuria (PKU) Market has been segmented into
The report offers in-depth assessment of the growth and other aspects of the Phenylketonuria (PKU) Market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
Phenylketonuria (PKU) Market highlights the potential growth opportunities in upcoming years, while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects in the global market. The Global Phenylketonuria (PKU) Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. This Research Study compares the markets of Pre COVID-19 and Post COVID-19 with the impact of COVID-19 on the regional economy.
Report Attributes | Report Details |
Report Title | Phenylketonuria (PKU) Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players Biomarin, Vitaflo, Mead Johnson, Nutricia, Abbott, Dr. Schär, Prominmetabolics, Cambrooke, Juvela, Firstplay Dietary and others. |
Forecast Period 2022 to 2028 CAGR | CAGR of 7.8% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Biomarin, Vitaflo, Mead Johnson, Nutricia, Abbott, Dr. Schär, Prominmetabolics, Cambrooke, Juvela, Firstplay Dietary and others. |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 133 |
Customization Available | Yes, the report can be customized as per your needs |
Frequently Asked Questions
What is the study period of this market?
The Phenylketonuria (PKU) Market is studied from 2017 - 2027.
What is the growth rate of Phenylketonuria (PKU) Market?
The Phenylketonuria (PKU) Market is growing at a CAGR of 7.8% over the next 5 years.
Who are the key players in Phenylketonuria (PKU) Market?
Biomarin, Vitaflo, Mead Johnson, Nutricia, Abbott, Dr. Schär, Prominmetabolics, Cambrooke, Juvela, Firstplay Dietary and others.
What regions does this Phenylketonuria (PKU) Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Phenylketonuria (PKU) Market?
Medications, Supplements, Others
What are the major end-use applications of the Phenylketonuria (PKU) Market?
Household, Hospital, Others
All our reports are customizable to your company's needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
Application_List
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.
